Yonhap Infomax NewsNov 25
Samsung Bioepis has promoted two Executive Vice Presidents and four Senior Vice Presidents in a performance-based leadership reshuffle, highlighting expertise in clinical development, manufacturing, regulatory affairs, and business strategy.
#YonhapInfomax #SamsungBioepis #ExecutivePromotion #Biosimilars #ClinicalDevelopment #BusinessStrategy #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=92338
Samsung Bioepis Promotes Two Executive Vice Presidents in Leadership Reshuffle

Samsung Bioepis has promoted two Executive Vice Presidents and four Senior Vice Presidents in a performance-based leadership reshuffle, highlighting expertise in clinical development, manufacturing, regulatory affairs, and business strategy.

Yonhap Infomax
Veeda Clinical ResearchJun 16, 2020

We offer quality solutions from #clinicaldevelopment to post #regulatory submission. Our expertise spans across multiple therapeutic areas, phases of #clinicaltrials, special areas such as Inhalation, Glucose Clamps, #Biosimilars etc.

For business inquiries, write to us at [email protected] or visit www.veedacr.com